NON-VALVULAR ATRIAL FIBRILLATION
Clinical trials for NON-VALVULAR ATRIAL FIBRILLATION explained in plain language.
Never miss a new study
Get alerted when new NON-VALVULAR ATRIAL FIBRILLATION trials appear
Sign up with your email to follow new studies for NON-VALVULAR ATRIAL FIBRILLATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common blood thinner shield your brain from dementia?
Disease control CompletedThis completed study looked at whether two different blood thinners—dabigatran (Pradaxa) and warfarin (Coumadin)—could help prevent memory loss and dementia in people over 65 with atrial fibrillation (an irregular heartbeat). A total of 101 participants were randomly assigned to …
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: PHASE4 • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for stroke prevention: device offers alternative to blood thinners for heart patients
Disease control CompletedThis study tested the WATCHMAN device, a small implant that closes off a part of the heart where clots often form, in 481 people with atrial fibrillation who cannot take blood thinners. The goal was to see if the device is safe and effective at reducing stroke risk. Participants …
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Researchers fine-tune blood thinner dosing for chinese heart patients
Knowledge-focused CompletedThis study looked at how the blood thinner edoxaban behaves in 150 Chinese adults with non-valvular atrial fibrillation (an irregular heartbeat). The goal was to see if current dosing models fit Chinese patients and to create a more personalized dosing plan to improve effectivene…
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New study sets standard blood levels for stroke prevention drugs in chinese patients
Knowledge-focused CompletedThis study measured the amount of common blood thinners (dabigatran, apixaban, and rivaroxaban) in the blood of 308 Chinese adults with atrial fibrillation who had been taking the medication for at least 3 months. The goal was to establish normal reference ranges for these drugs …
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC